Wissam Khalife, M.D., F.A.C.C., M.A.A.C.
Assistant Professor, Division of Cardiology
Wissam Khalife, M.D., F.A.C.C., M.A.A.C.
Assistant Professor
Interim Director of Heart Failure, Cardiac Transplant and Left Ventricular Assist Device Program
Division of Cardiology
Department of Internal Medicine
University of Texas Medical Branch
301 University Blvd.
Galveston, TX 77555-1060
Phone: 409.772.9835
wikhalif@utmb.edu
Clinical Expertise
- Heart Failure and Transplantation
- Invasive Cardiology and Invasive Heart Failure
- Cardiac Imaging
Research Interests
- Diastolic Heart Failure: etiology and management
- Effects of exercise and life style modification on heart failure
- Radial approach for coronary angiogram: an academic institutional experience
Overview
Dr. Khalife is an Assistant Professor of Medicine at the UTMB Division of Cardiology. His educational background includes Heart Failure/Transplant Fellowship at Baylor College of Medicine/Texas Heart Institute and Cardiology Fellowship at UTMB. He is Board certified in Internal Medicine, Cardiovascular disease, Heart Failure and transplantation, Echocardiography, and Nuclear Cardiology. He was awarded the title of Master of the American Academy of Cardiology in 2010.
Dr. Khalife is currently the Interim Director of the Heart Failure/Transplant and Left ventricular assist device Program at UTMB. He is interested in invasive cardiology, invasive heart failure and transplant as well as cardiology imaging. He has multiple ongoing research projects and many publications.
Education
| Degree | Year | Institution |
| B.A. | 1992 | Lebanese University |
| M.D. | 1999 | Lebanese University |
| Residency Traditional Year Internal Medicine |
2000 2005 |
Lebanese University University of South Dakota |
| Fellowship Heart Failure & Cardiac Transplantation Cardiovascular Disease |
2006 2009 |
Texas Heart Institute/Baylor College of Medicine University of Texas Medical Branch |
Select Publications
- Sirolimus-induced alveolar hemorrhage. Wissam I. Khalife, Kogoj B, Biswajit Kar. J Heart Lung Transplant. 2007 Jun;26(6):652-7. Epub 2007 Apr 16.
- The TandemHeart pVAD in the treatment of acute fulminant myocarditis. Wissam I. Khalife, Biswajit Kar. Tex Heart Inst J. 2007;34(2):209-13.
- Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. Wissam I Khalife, Tang YD, Kuzman JA, Thomas TA, Anderson BE, Said S, Tille P, Schlenker EH, Gerdes AM. Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2409-15. Epub 2005 Jul 15.
- Impending cardiac tamponade as a primary presentation of hypothyroidism: case report and review of literature. Andru K Karu, Wissam I Khalife, Robert Houser, John Van Derwoude. Endocr Pract. 2005 Jul-Aug;11(4):265-71.
- Pulmonary lymphangioleiomyomatosis in a postmenopausal woman: case report with review of literature. Wissam I. Khalife, Fade Mahmoud, Eric Larson, Richard Hardie. S D J Med. 2005 Apr;58(4):139-43. Review.
- Respiratory failure secondary to methemoglobinemia induced by benzocaine: a case report. Wissam I Khalife, Rong Wang, Jihad Khalil. S D J Med. 2004 Apr;57(4):145-7.
- Dilated cardiomyopathy, inferior myocardial infarction and severe mitral regurgutation as cardiac complications of Berardinelli-Seip syndrome. Wissam I. Khalife, Manal Mourtada, Jihad Khalil. Tex Heart Inst J, June 2008;35(2):1-4.
- Heart disease in patients with HIV/ AIDS: An emerging clinical problem. Muralikrishna Gopalakrishamoorthy, Archana Bhaskaran, Wissam I. Khalife, N.A. Barbagelata. Current Cardiology Reviews 2009, Volume 05, No. 02.
- Renal angiomyolipoma: clinical study with review of literature. Wissam I Khalife, Manal C. Mourtada, Sami Zeineddine. Lebanese University. Volume: 1, Pages: 1-50. October 1999.
- Diastolic Dysfunction (DD) is a useful marker to risk stratify patients with frequent COPD eexacerbations and normal left ventricular ejection fraction (LVEF). Ghassan Abusaid, Wissam I Khalife, N A Barbagelata, Gulshan Sharma, Enrique Tuero. Abstract presented at the 12th Annual Scientific meeting of the Heart Failure Society of America (September 21-24, 2008, Toronto, ON, Canada).
Featured Videos
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.
Currently available protocols are:- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.
